RxDoctor Payments Data

Edward McClain, MD

Orthopedic Surgery · Pittsburgh, PANPI 1518932243

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Zimmer Biomet at 41.6% of the total. Reporting peaked in 2024 at $261 and has fallen 60.5% since, to $103 in 2025.

$1,179in general payments, 2019–2025

Across 14 payments — averaging $84.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$490
  • Stryker$303
  • Johnson & Johnson$228
  • Smith+Nephew$158

What the payments were for

  • Food & beverage$1,179100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet5$490
Stryker4$303
Johnson & Johnson3$228
Smith+Nephew2$158

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,179 in reported general payments places this provider in the 65th percentile of 43 orthopedic surgery providers in Pennsylvania.

See all orthopedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$226,169
Medicare patients
393
Services billed
3,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin245$1,217
Meloxicam363$1,006
Ibuprofen28$362
Gabapentin65$340
Amoxicillin123$262
Diclofenac Sodium13$255
Oxycodone Hcl49$238
Celecoxib18$238
IbuIbuprofen19$205
Methylprednisolone32$161
Clindamycin Hcl31$85
Prednisone21$52
Naproxen14$44
Cephalexin14$33
Metronidazole22$19

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →